geeboy30
- 20 Jul 2004 16:30
hello
i have been given a little tip to put some of my hard earned into this company.
do any of you guys who know how to run the rule over companies have any views on how good a bet this company would be?
cheers
kate bates
- 22 Jul 2010 13:51
- 4 of 15
I bought some you may indeed be correct, the 100,000 buy this morn quite an eyecatcher, director buying or even more interesting?
bertyknows
- 26 Jul 2010 07:58
- 5 of 15
very good news out this morning everyone.
kate bates
- 26 Jul 2010 08:21
- 6 of 15
looks like somebody knew of contract, excellent news and we should see this rise back to 200p.
queen1
- 26 Jul 2010 12:57
- 7 of 15
Agreed Kate, onwards and upwards!
kate bates
- 28 Jul 2010 10:06
- 8 of 15
i just bought a few more here queenie with a target of 200p in mind
queen1
- 28 Jul 2010 12:57
- 9 of 15
In a World where an ever increasing population is going to have to feed from an ever decreasing food pool, this could fly into the sky....
kate bates
- 28 Jul 2010 21:53
- 10 of 15
yes queenie that is good comment, I'm more than happy to build a decent stake here awaiting the bigger deals which should start accumulating this nect 6-18 mths.
deputy
- 02 Aug 2010 22:29
- 11 of 15
wish you luck
deputy
- 02 Aug 2010 22:30
- 12 of 15
wish you luck
queen1
- 27 Jul 2012 13:42
- 13 of 15
Great news for PHC - I'm surprised there's not more of a following on here:
Plant Health Care has announced that in recent trials it was found that potatoes, when treated with its proprietary Harpin technology while still in the field, produced a 4.4% greater marketable yield at harvest. It also reduced loss in long-term (7-8 month) storage from 4.6% in the untreated to 1.9% in the treated tubers.
The storage improvements alone are worth about $4 per ton, which equates to $20,000 for a 5,000 ton storage building. These results were achieved in trials conducted by independent crop consultants using commercial production practices in grower fields in Washington and Idaho.
Harpin technology is available for all major crops. The Harpins bind to receptors on the surface of the plant leaf, causing a reaction where the plant gears up to defend itself against disease.
This is the well-documented Systematic Acquired Resistance (SAR) response, which affects the yield quality and shelf life of the crops. PHC currently has several testing agreements with major companies looking at disease control, yield increase and longer, post- harvest, shelf life achieved through the combined use of Harpin and fungicide.
Paul Bystrak, PHC Field Scientist, commented: "We had already seen evidence in smaller-scale studies that the long-term storability of potatoes increased following in-field Harpin treatment, so it is very encouraging to have those results verified on a larger scale. We have also demonstrated similar results in a variety of crops ranging from lettuce to citrus, so the financial savings potential for the grower should prove to be very attractive."
HARRYCAT
- 21 Dec 2018 08:03
- 15 of 15

StockMarketWire.com
Pesticides supplier Plant Health Care warned its annual revenue would be 'substantially' below market expectations following drought conditions in South Africa and a delayed shipment to Brazil.
Revenue for the year through December was now expected to be flat on-year, the company said.
Expectations for 2019, meanwhile, remained unchanged, it added.
'In South Africa, which has been a major contributor in prior years, prolonged drought has resulted in slower draw-down than expected on in-market inventory,' Plant Health Care said.
'As a result, we have decided to restrict sales until inventory has been worked off.'
Sales in Brazil had continued a positive trend in sugarcane, as expected. However, an additional shipment to Brazil may fall into 2019 due to delays in clearing customers.
Plant Health Care said the launch of a new Harpin product into corn with a major US partner 'has made a very encouraging start and delivered sales close to $1.5m'.
A planned launch with the partner into soy, however, had been delayed into 2019.
'While the shortfall against expectations is extremely disappointing, our expectations for sales in 2019 are unchanged,' chief executive Chris Richards said.
'We are very encouraged by progress in the US and Brazil.'
'The shortfall in 2018 does not affect the board's confidence in the company becoming cash positive no later than 2020, within our existing cash reserves.'